Literature DB >> 10567642

Characterization of infectious Murray Valley encephalitis virus derived from a stably cloned genome-length cDNA.

Robert J Hurrelbrink1, Ann Nestorowicz2, Peter C McMinn1.   

Abstract

An infectious cDNA clone of Murray Valley encephalitis virus prototype strain 1-51 (MVE-1-51) was constructed by stably inserting genome-length cDNA into the low-copy-number plasmid vector pMC18. Designated pMVE-1-51, the clone consisted of genome-length cDNA of MVE-1-51 under the control of a T7 RNA polymerase promoter. The clone was constructed by using existing components of a cDNA library, in addition to cDNA of the 3' terminus derived by RT-PCR of poly(A)-tailed viral RNA. Upon comparison with other flavivirus sequences, the previously undetermined sequence of the 3' UTR was found to contain elements conserved throughout the genus FLAVIVIRUS: RNA transcribed from pMVE-1-51 and subsequently transfected into BHK-21 cells generated infectious virus. The plaque morphology, replication kinetics and antigenic profile of clone-derived virus (CDV-1-51) was similar to the parental virus in vitro. Furthermore, the virulence properties of CDV-1-51 and MVE-1-51 (LD(50) values and mortality profiles) were found to be identical in vivo in the mouse model. Through site-directed mutagenesis, the infectious clone should serve as a valuable tool for investigating the molecular determinants of virulence in MVE virus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567642     DOI: 10.1099/0022-1317-80-12-3115

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein.

Authors:  R J Hurrelbrink; P C McMinn
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Infectious cDNA clone of the epidemic west nile virus from New York City.

Authors:  Pei-Yong Shi; Mark Tilgner; Michael K Lo; Kim A Kent; Kristen A Bernard
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Construction and characterisation of a complete reverse genetics system of dengue virus type 3.

Authors:  Jefferson José da Silva Santos; Marli Tenório Cordeiro; Giovani Rota Bertani; Ernesto Torres de Azevedo Marques; Laura Helena Vega Gonzales Gil
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-12       Impact factor: 2.743

4.  Generation of stable infectious clones of plant viruses by using Rhizobium radiobacter for both cloning and inoculation.

Authors:  Decai Tuo; Lanlan Fu; Wentao Shen; Xiaoying Li; Peng Zhou; Pu Yan
Journal:  Virology       Date:  2017-07-14       Impact factor: 3.616

Review 5.  Flavivirus reverse genetic systems, construction techniques and applications: a historical perspective.

Authors:  Fabien Aubry; Antoine Nougairède; Ernest A Gould; Xavier de Lamballerie
Journal:  Antiviral Res       Date:  2014-12-12       Impact factor: 5.970

6.  An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system.

Authors:  Klaus K Orlinger; Georg W Holzer; Julia Schwaiger; Josef Mayrhofer; Karl Schmid; Otfried Kistner; P Noel Barrett; Falko G Falkner
Journal:  Vaccine       Date:  2010-03-06       Impact factor: 3.641

Review 7.  Structure and functionality in flavivirus NS-proteins: perspectives for drug design.

Authors:  Michela Bollati; Karin Alvarez; René Assenberg; Cécile Baronti; Bruno Canard; Shelley Cook; Bruno Coutard; Etienne Decroly; Xavier de Lamballerie; Ernest A Gould; Gilda Grard; Jonathan M Grimes; Rolf Hilgenfeld; Anna M Jansson; Hélène Malet; Erika J Mancini; Eloise Mastrangelo; Andrea Mattevi; Mario Milani; Grégory Moureau; Johan Neyts; Raymond J Owens; Jingshan Ren; Barbara Selisko; Silvia Speroni; Holger Steuber; David I Stuart; Torsten Unge; Martino Bolognesi
Journal:  Antiviral Res       Date:  2009-11-27       Impact factor: 5.970

8.  Complete genome sequences of the prototype isolates of genotypes 2, 3, and 4 of murray valley encephalitis virus.

Authors:  David T Williams; Sinéad M Diviney; Karli J Corscadden; Beng Hooi Chua; John S Mackenzie
Journal:  Genome Announc       Date:  2014-06-19

Review 9.  RNA virus reverse genetics and vaccine design.

Authors:  Christopher C Stobart; Martin L Moore
Journal:  Viruses       Date:  2014-06-25       Impact factor: 5.048

10.  The Molecular Epidemiology and Evolution of Murray Valley Encephalitis Virus: Recent Emergence of Distinct Sub-lineages of the Dominant Genotype 1.

Authors:  David T Williams; Sinéad M Diviney; Aziz-ur-Rahman Niazi; Peter A Durr; Beng Hooi Chua; Belinda Herring; Alyssa Pyke; Stephen L Doggett; Cheryl A Johansen; John S Mackenzie
Journal:  PLoS Negl Trop Dis       Date:  2015-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.